Web Stats Provided By Google Analytics

Tuesday, January 21, 2014

Affymetrix Receives FDA Clearance of First-of-its-kind Postnatal Test ...

This assay is intended for the postnatal detection of DNA copy number variants in patients referred for chromosomal testing.

http://ift.tt/1jkA6Ch

No comments:

Post a Comment

Popular Healthcare Law Roundup Posts